GGrantIndex
Sort

50,496 grants matching lung cancer

Viral Interface with an Interferon-Induced Gene

$462,573
Nancy C. Reich · State University New York Stony Brook · R01 · FY2014 · AI

Translational Research Training Program in Environmental Health Sciences

$462,540
Trevor M. Penning · University Of Pennsylvania · T32 · FY2022 · ES

Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice

$462,539
Harold E Varmus · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA

Support for the Central Data Collection Center (CDCC)

$462,520
Sunitha Mathew · Westat, Inc. · N02 · FY2025 · CA

MOLECULAR BIOLOGY OF JAAGSIEKTE SHEEP RETROVIRUS

$462,493
University Of California Irvine · R01 · FY2002 · CA

Mutation Screening of Nicotine and Alcohol Dependence

$462,486
Washington University · R01 · FY2004 · AA

A Fragment-Based Strategy for K-RAS Covalent Inhibitors

$462,460
Samy Meroueh · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA

Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer

$462,419
Justin Pritchard · Pennsylvania State University, The · U01 · FY2021 · CA

Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressio

$462,399
Jay Copeland Strum · G1 Therapeutics, Inc. · R44 · FY2014 · CA

Skeletal Muscle Atrophy and Dysfunction in Human Cancer

$462,369
Michael J Toth · University Of Vermont & St Agric College · R01 · FY2021 · AR

Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance

$462,328
Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Discovery of novel PCFT-targeted agents

$462,299
Larry H. Matherly · Wayne State University · R01 · FY2011 · CA

Novel approaches to study immune responses to post translational modifications for cancer detection

$462,286
Joshua Labaer · Arizona State University-Tempe Campus · U01 · FY2017 · CA

High-Throughput De Novo Glycan Sequencing

$462,286
Cheng Lin · Boston University Medical Campus · R01 · FY2019 · GM

Metabolism of Carcinogenic Tobacco-Specific Nitrosamines

$462,212
University Of Minnesota Twin Cities · R37 · FY2004 · CA

Role of the Plasminogen Activator Protease during Pneumonic Plague

$462,195
Wyndham W. Lathem · Northwestern University At Chicago · R01 · FY2017 · AI

Dual Targeting Redox‐active Gold(I) Therapeutics

$462,195
Kuppuswamy Arumugam · Wright State University · R15 · FY2018 · CA

Understanding the induction of T cell dysfunction in the context of lung cancer

$462,141
Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2025 · CA

The role of wild-type KRAS in the context of tumor profession and metastasis

$462,118
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2017 · CA

Stress Induction of Glucose Regulated Protein GRP78/BiP

$462,114
Amy S Lee · University Of Southern California · R01 · FY2016 · CA

Chemoprevention of lung cancer with red ginseng extracts

$462,108
Ming You · Medical College Of Wisconsin · R01 · FY2011 · AT

Project 2: The Impact of Immunotherapy on Human Vaccination

$462,053
E. John Wherry · Massachusetts General Hospital · U19 · FY2023 · AI

Neurology and the molecular role of N-RBPs in the brain

$462,020
Robert B Darnell · Rockefeller University · R01 · FY2008 · NS

Neuroprotection for chemotherapy induced peripheral neuropathy

$462,000
In Hong Yang · University Of North Carolina Charlotte · R15 · FY2024 · CA

University of Maryland, Baltimore Biomarker Reference Laboratory

$461,999
Sanford A Stass · University Of Maryland Baltimore · U24 · FY2016 · CA